This week, a panel of leading rheumatologists joined us to discuss the risks of COVID-19 for people living with rheumatological diseases, key insights from the COVID-19 Global Rheumatology Alliance, and if and how to adapt therapy during the current pandemic.

With a live cross to the UK, we heard from Dr James Galloway, a  rheumatologist and clinical researcher, about his experience managing patients on the frontline, as well as insights into the clinical trials currently exploring potential treatments for COVID-19.

Watch the full recording here: 

Listen to the podcasts here: 

the limbic · What does the COVID-19 pandemic mean for rheumatology now and in the future
This webinar was developed independently by the limbic. Thank you to Pfizer Australia Pty Ltd for providing the financial support that made it possible.